ResearcherUniversitat Autònoma de BarcelonaNo recent work listed
Gerard Urrútia
Matched on ORCID iD 0000-0002-8850-0960; OpenAlex author ID A5047473333. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2021: 1 paper · 2022: none · 2023: 2 papers
Papers 3
- Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map. Co-author DOI 10.1007/s00520-022-07564-8↗
- Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review. Last author DOI 10.1186/s12885-023-11207-4↗
- Efficacy of systemic oncological treatments in patients with advanced pancreatic cancer at high risk of dying in the short or medium-term: overview of systemat… Co-author DOI 10.1016/j.ejca.2021.05.034↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Josefina Salazar · 3 shared papers, 2021–2023 · strength 0.36
- Paper Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map. DOI 10.1007/s00520-022-07564-8↗
- Paper Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review. DOI 10.1186/s12885-023-11207-4↗
- Paper Efficacy of systemic oncological treatments in patients with advanced pancreatic cancer at high risk of dying in the sh… DOI 10.1016/j.ejca.2021.05.034↗
- Xavier Bonfill · 3 shared papers, 2021–2023 · strength 0.36
- Paper Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map. DOI 10.1007/s00520-022-07564-8↗
- Paper Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review. DOI 10.1186/s12885-023-11207-4↗
- Paper Efficacy of systemic oncological treatments in patients with advanced pancreatic cancer at high risk of dying in the sh… DOI 10.1016/j.ejca.2021.05.034↗
- Miguel Sugrañes · 1 shared paper, 2023 · strength 0.13
- Carles Pericay Pijaume · 1 shared paper, 2023 · strength 0.13
- Luis Carlos Saiz Fernández · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.